Key facts
| Recalling firm | GE Healthcare Finland Oy |
|---|---|
| Manufacturer | Not disclosed in the FDA record. |
| Brand name | Not disclosed in the FDA record. |
| Product description | CARESCAPE Canvas Smart Display, Model Numbers: a) 5700023, b) 5700023-02, c) 5939590-102; monitor, physiological, patient |
| Classification | Class II |
| Recall number | Z-2169-2024 |
| Report date | Not disclosed in the FDA record. |
| Status | Ongoing |
| Reason for recall | GE HealthCare has become aware of the potential for loss of monitoring on CARESCAPE Canvas 1000, CARESCAPE Canvas Smart Display, and certain versions of CARESCAPE B850 and CARESCAPE B650 monitors if, following the replacement of the CPU timekeeper battery, a mains power loss occurs during active monitoring. In the unlikely event that this occurs, it can result in the displays or monitors not turning on, after the mains power is restored. This can result in a delay in recognizing changes in patient condition until a replacement monitor is connected. |
What this classification means
A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. FDA still requires the recalling firm to notify affected accounts and submit status reports on the correction, though the monitoring intensity is lower than for a Class I recall. FDA's Center for Devices and Radiological Health (for devices) or Center for Drug Evaluation and Research (for drugs) reviews the classification and can require additional corrective action if the initial response is judged insufficient. Because this record is filed as Class II, professionals and consumers handling an affected lot should treat FDA's own classification -- not this page's summary of it -- as the authoritative risk signal. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field.
What consumers should do
Facilities, clinicians, and consumers holding an affected unit or lot of CARESCAPE Canvas Smart Display, Model Numbers: a) 5700023, b) 5700023-02, c) 5939590-102; monitor, physiological, patient should stop using it for the purpose described in the recall notice and hold remaining stock pending instructions from GE Healthcare Finland Oy. FDA recall records typically direct the recalling firm to notify known accounts directly with a recall letter describing the specific corrective action -- replacement, field correction, refund, or return. Anyone who received the product through a distributor rather than directly from GE Healthcare Finland Oy should confirm with their supplier whether their specific lot or unit is on the affected list, since recall notices are lot- or unit-specific and not every unit of a product line is necessarily included. Questions about a specific unit's status should go to GE Healthcare Finland Oy directly or to the distributor that supplied it; Argus HQ is a public-record aggregator, not the recalling firm, and cannot confirm individual unit status.
GE Healthcare Finland Oy’s FDA history
Argus HQ has recorded 19 total FDA actions tied to GE Healthcare Finland Oy: 0 warning letters, 19 recalls, 0 approval records, and 0 Form 483 inspection citations.
Frequently asked questions
- What is the FDA recall number for this event?
- FDA recall number Z-2169-2024.
- What is the current status of this recall?
- Status as recorded by FDA: Ongoing.
- Where can I verify this recall directly with FDA?
- The verbatim FDA record is the source of truth for every recall Argus HQ tracks — always confirm against fda.gov before acting.
- Is CARESCAPE Canvas Smart Display, Model Numbers: a) 5700023, recalled?
- Yes. FDA lists a Class II recall by GE Healthcare Finland Oy for CARESCAPE Canvas Smart Display, Model Numbers: a) 5700023, b) 5700023-02, c) 5939590-102; monitor, physiological, patient, reported 20240703, with status "Ongoing." FDA recall number: Z-2169-2024.
Know if this happens again — we'll email you.
Free. No spam, just recall alerts for what you tell us to watch.
Related enforcement actions
Full FDA history for GE Healthcare Finland Oy- Recall: GE Healthcare Finland Oy — Class II recall: BATTERY FLEX-3S2P 10.8V 18650 LI-ION SMBUS used with affected patient monitors… →
- Recall: GE Healthcare Finland Oy — Class II recall: Portrait VSM Model nos. 6660000-666 Monitor, Physiological, Patient (With… →
- Recall: GE Healthcare Finland Oy — Class II recall: Carescape B450, Model no. 5805686 - shipped with potentially affected batteries… →
- Recall: GE Healthcare Finland Oy — Class II recall: CARESCAPE ONE, Model no. 2087075-300 - shipped with potentially affected batteri… →
- Recall: GE Healthcare Finland Oy — Class II recall: B105P, B125P, B105M, B125M, B155M Patient Monitors; Model nos. 6160000-002 61600… →
- Recall: GE Healthcare Finland Oy — Class II recall: CARESCAPE Canvas Smart Display, Model Numbers: a) 5514418, b) 5514418 / MAE… →
- Recall: GE Healthcare Finland Oy — Class II recall: CARESCAPE Canvas 1000, Model Numbers: a) 5865770; b) 5865770-01040169; c) 58… →
- Recall: GE Healthcare Finland Oy — Class II recall: CARESCAPE B650: Model Numbers: a) MBB313, Model Numbers: 1) 2095801-001, 2… →
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2024). FDA Class II Recall: CARESCAPE Canvas Smart Display, Model Numbers: a) 5700023,… by GE Healthcare Finland Oy. Digital Empire LLC. Retrieved from https://argushq.ai/recall/ge-healthcare-finland-oy-z-2169-2024-2024-07-03
"FDA Class II Recall: CARESCAPE Canvas Smart Display, Model Numbers: a) 5700023,… by GE Healthcare Finland Oy." Argus HQ Research, Digital Empire LLC, 2024, argushq.ai/recall/ge-healthcare-finland-oy-z-2169-2024-2024-07-03.
Argus HQ Research. "FDA Class II Recall: CARESCAPE Canvas Smart Display, Model Numbers: a) 5700023,… by GE Healthcare Finland Oy." Digital Empire LLC. Accessed July 17, 2026. https://argushq.ai/recall/ge-healthcare-finland-oy-z-2169-2024-2024-07-03.
@misc{argushq_argushq_ai_recall_ge_healthcare_finland_oy_z_2169_2024_2024_07_03_2024,
title = {FDA Class II Recall: CARESCAPE Canvas Smart Display, Model Numbers: a) 5700023,… by GE Healthcare Finland Oy},
author = {{Argus HQ Research}},
year = {2024},
publisher = {Digital Empire LLC},
url = {https://argushq.ai/recall/ge-healthcare-finland-oy-z-2169-2024-2024-07-03},
note = {Accessed: July 17, 2026}
}Source: FDA.gov — Recalls ↗

